F
Francesc Balaguer
Researcher at University of Barcelona
Publications - 241
Citations - 8187
Francesc Balaguer is an academic researcher from University of Barcelona. The author has contributed to research in topics: Colorectal cancer & Cancer. The author has an hindex of 42, co-authored 194 publications receiving 6594 citations. Previous affiliations of Francesc Balaguer include Baylor University & Baylor University Medical Center.
Papers
More filters
Journal ArticleDOI
Rectal Aberrant Crypt Foci in Humans Are Not Surrogate Markers for Colorectal Cancer Risk.
Isabel Quintanilla,María López-Cerón,Mireya Jimeno,Miriam Cuatrecasas,Michel Zabalza,Leticia Moreira,Virginia Alonso,Cristina Rodríguez de Miguel,J. Munoz,Sergi Castellví-Bel,Josep Llach,Antoni Castells,Francesc Balaguer,Jordi Camps,Maria Pellise +14 more
TL;DR: Although aberrant crypt foci might be preneoplastic lesions of the colon, they are not suitable biomarkers for assessing CRC progression.
Journal ArticleDOI
Motorized Spiral Enteroscopy Is Effective in Patients with Prior Abdominal Surgery
Antonio Giordano,Gherzon Casanova,Miriam Escapa,Gloria Fernández-Esparrach,Angels Ginès,Oriol Sendino,Isis K. Araujo,Andrés Cárdenas,Henry Córdova,Julia Martinez-Ocon,Graciela Martínez-Pallí,Francesc Balaguer,Josep Llach,Elena Ricart,Begoña González-Suárez +14 more
TL;DR: In this paper , a prospective observational study was conducted on patients undergoing MSE from June 2019 to December 2021, where the authors collected demographic characteristics, procedure time, depth of maximum insertion (DMI), technical success, diagnostic yield, and adverse events were collected.
Journal ArticleDOI
Síndromes de predisposición a cáncer gástrico y cáncer pancreático
Maria Liz Leoz,Ariadna Sánchez,Sabela Carballal,Lucía Ruano,Teresa Ocaña,Maria Pellise,Antoni Castells,Francesc Balaguer,Leticia Moreira +8 more
TL;DR: This work reviews the hereditary and familial syndromes associated with gastric and pancreatic cancers with a view to improving knowledge and understanding of these diseases, in order to heighten diagnostic suspicion and thus implement appropriate diagnostic strategies, screening, surveillance and treatment.
Journal ArticleDOI
LINE-1 hypomethylation is neither present in rectal aberrant crypt foci nor associated with field defect in sporadic colorectal neoplasia
Isabel Quintanilla,María López-Cerón,Mireya Jimeno,Miriam Cuatrecasas,J. Munoz,Leticia Moreira,Sabela Carballal,Maria Liz Leoz,Jordi Camps,Antoni Castells,Maria Pellise,Francesc Balaguer +11 more
TL;DR: The results suggest that global hypomethylation is not present in rectal ACF and argues against the existence of LINE-1 methylation field defect in sporadic colon cancer.
Journal ArticleDOI
miRNome Profiling and Functional Analysis Reveal Involvement of hsa-miR-1246 in Colon Adenoma-Carcinoma Transition by Targeting AXIN2 and CFTR
Rokas Lukoševičius,Simonas Juzenas,Violeta Salteniene,Ugne Kulokiene,J. Arstikyte,Georg Hemmrich-Stanisak,Andre Franke,Alexander Link,Paulius Ruzgys,Saulius Šatkauskas,Henrikas Pauzas,Tadas Latkauskas,Gediminas Kiudelis,Francesc Balaguer,Juozas Kupcinskas,Jurgita Skieceviciene +15 more
TL;DR: Possible involvement of hsa-miR-1246 in early colorectal cancer development and regulation of tumor suppressors AXIN2 and CFTR is revealed.